Allergy and allergic mediators in tears

Experimental Eye Research

Volumn 117, Issue , 2013, Pages 106-117

  Leonardi, Andrea ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Allergic conjunctivitis; Biomarkers; Cytokines; Mediators; Tears

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; CALCITONIN; CHYMASE; CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; EOTAXIN; GAMMA INTERFERON; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE; MAJOR BASIC PROTEIN; MESSENGER RNA; MUCIN; NERVE GROWTH FACTOR; NEUROTOXIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; SUBSTANCE P; TRYPTASE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ATOPIC KERATOCONJUNCTIVITIS; CONTACT BLEPHAROCONJUNCTIVITIS; CYTOLOGY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE ALLERGY; GIANT PAPILLARY CONJUNCTIVITIS; HUMAN; IMMUNOADSORBENT; LACRIMAL FLUID; MAST CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OXIDATIVE STRESS; PERENNIAL ALLERGIC CONJUNCTIVITIS; PRIORITY JOURNAL; REVIEW; SEASONAL ALLERGIC CONJUNCTIVITIS; SENSITIZATION; STAPHYLOCOCCUS AUREUS; TANDEM MASS SPECTROMETRY; TEAR FILM; TEST STRIP; TWO DIMENSIONAL GEL ELECTROPHORESIS; VERNAL CONJUNCTIVITIS;

ALLERGIC CONJUNCTIVITIS; BIOMARKERS; CYTOKINES; MEDIATORS; TEARS;

ALLERGENS; BIOLOGICAL MARKERS; CONJUNCTIVITIS, ALLERGIC; CYTOKINES; HUMANS; PROTEOMICS; TEARS;

EID: 84888128400     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.07.019     Document Type: Review

References (89)

1. Abelson M.B., Leonardi A.A., Smith L.M., Fregona I.A., George M.A., Secchi A.G. Histaminase activity in patients with vernal keratoconjunctivitis. Ophthalmology 1995, 102:1958-1963.
2. Anderson D.F., MacLeod J.D., Baddeley S.M., Bacon A.S., McGill J.I., Holgate S.T., Roche W.R. Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration. Clin. Exp. Allergy 1997, 27:1060-1066.
3. Anderson D.F., Zhang S., Bradding P., McGill J.I., Holgate S.T., Roche W.R. The relative contribution of mast cell subsets to conjunctival TH2-like cytokines. Invest. Ophthalmol. Vis. Sci. 2001, 42:995-1001.
4. Avunduk A.M., Avunduk M.C., Tekelioglu Y. Analysis of tears in patients with atopic keratoconjunctivitis, using flow cytometry. Ophthalmic Res. 1998, 30:44-48.
5. Bacon A.S., Ahluwalia P., Irani A.M., Schwartz L.B., Holgate S.T., Church M.K., McGill J.I. Tear and conjunctival changes during the allergen-induced early- and late-phase responses. J.Allergy Clin. Immunol. 2000, 106:948-954.
6. Bacsi A., Dharajiya N., Choudhury B.K., Sur S., Boldogh I. Effect of pollen-mediated oxidative stress on immediate hypersensitivity reactions and late-phase inflammation in allergic conjunctivitis. J.Allergy Clin. Immunol. 2005, 116:836-843.
7. Bonini S., Bonini S., Bucci M.G., Berruto A., Adriani E., Balsano F., Allansmith M.R. Allergen dose response and late symptoms in a human model of ocular allergy. J.Allergy Clin. Immunol. 1990, 86:869-876.
8. Bonini S., Schiavone M., Bonini S., Magrini L., Lischetti P., Lambiase A., Bucci M.G. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis. Ophthalmology 1997, 104:849-853.
9. Bonini S., Tomassini M., Adriani E., Magrini L., Rumi C., Bussa S., Ronchetti F., Bonini S. Markers of eosinophilic inflammation in allergic diseases. Allergy 1993, 48:133-137. discussion 143-135.
10. Butrus S.I., Ochsner K.I., Abelson M.B., Schwartz L.B. The level of tryptase in human tears. An indicator of activation of conjunctival mast cells. Ophthalmology 1990, 97:1678-1683.
11. Callebaut I., Spielberg L., Hox V., Bobic S., Jorissen M., Stalmans I., Scadding G., Ceuppens J.L., Hellings P.W. Conjunctival effects of a selective nasal pollen provocation. Allergy 2010, 65:1173-1181.
12. Cook E.B. Tear cytokines in acute and chronic ocular allergic inflammation. Curr. Opin. Allergy Clin. Immunol. 2004, 4:441-445.
13. Cook E.B., Stahl J.L., Lowe L., Chen R., Morgan E., Wilson J., Varro R., Chan A., Graziano F.M., Barney N.P. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J.Immunol. Methods 2001, 254:109-118.
14. Dartt D.A., Hodges R.R., Li D., Shatos M.A., Lashkari K., Serhan C.N. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. J.Immunol. 2011, 186:4455-4466.
15. Dogru M., Matsumoto Y., Okada N., Igarashi A., Fukagawa K., Shimazaki J., Tsubota K., Fujishima H. Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis. Allergy 2008, 63:1324-1334.
16. Dogru M., Okada N., Asano-Kato N., Igarashi A., Fukagawa K., Shimazaki J., Tsubota K., Fujishima H. Alterations of the ocular surface epithelial mucins 1, 2, 4 and the tear functions in patients with atopic keratoconjunctivitis. Clin. Exp. Allergy 2006, 36:1556-1565.
17. Dunford P.J., O'Donnell N., Riley J.P., Williams K.N., Karlsson L., Thurmond R.L. The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells. J.Immunol. 2006, 176:7062-7070.
18. Ebihara N., Funaki T., Takai S., Miyazaki M., Fujiki K., Murakami A. Tear chymase in vernal keratoconjunctivitis. Curr. Eye Res. 2004, 28:417-420.
19. Enriquez-de-Salamanca A., Bonini S., Calonge M. Molecular and cellular biomarkers in dry eye disease and ocular allergy. Curr. Opin. Allergy Clin. Immunol. 2012, 12:523-533.
20. Eperon S., Sauty A., Lanz R., Leimgruber A., Lurati F., Guex-Crosier Y. Eotaxin-1 (CCL11) up-regulation in tears during seasonal allergic conjunctivitis. Graefes Arch. Clin. Exp. Ophthalmol. 2004, 242:966-970.
21. Fujishima H., Takeuchi T., Shinozaki N., Saito I., Tsubota K. Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Clin. Exp. Immunol. 1995, 102:395-398.
22. Fukagawa K., Nakajima T., Tsubota K., Shimmura S., Saito H., Hirai K. Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J.Allergy Clin. Immunol. 1999, 103:1220-1221.
23. Ghavami S., Hashemi M., de Serres F.J., Bajestani S.N., Mehrabifar H., Leonardi A. Trypsin inhibitory capacity in vernal keratoconjunctivitis. Invest. Ophthalmol. Vis. Sci. 2007, 48:264-269.
24. Hayashi D., Li D., Hayashi C., Shatos M., Hodges R.R., Dartt D.A. Role of histamine and its receptor subtypes in stimulation of conjunctival goblet cell secretion. Invest. Ophthalmol. Vis. Sci. 2012, 53:2993-3003.
25. Hoffmann-Sommergruber K., Ferreira E.D., Ebner C., Barisani T., Korninger L., Kraft D., Scheiner O., Baumgartner I. Detection of allergen-specific IgE in tears of grass pollen-allergic patients with allergic rhinoconjunctivitis. Clin. Exp. Allergy 1996, 26:79-87.
26. Hori S., Shoji J., Inada N., Sawa M. Allergy related factors in tears of patients with vernal keratoconjunctivitis undergoing topical 0.1% tacrolimus treatment. Nihon Ganka Gakkai Zasshi 2011, 115:1079-1085.
27. Inada N., Shoji J., Kato H., Kiely S., Mulyanto, Sawa M. Clinical evaluation of total IgE in tears of patients with allergic conjunctivitis disease using a novel application of the immunochromatography method. Allergol. Int. 2009, 58:585-589.
28. Inic-Kanada A., Nussbaumer A., Montanaro J., Belij S., Schlacher S., Stein E., Bintner N., Merio M., Zlabinger G.J., Barisani-Asenbauer T. Comparison of ophthalmic sponges and extraction buffers for quantifying cytokine profiles in tears using Luminex technology. Mol. Vis. 2012, 18:2717-2725.
29. Irkec M.T., Orhan M., Erdener U. Role of tear inflammatory mediators in contact lens-associated giant papillary conjunctivitis in soft contact lens wearers. Ocul. Immunol. Inflamm. 1999, 7:35-38.
30. Jedrzejczak-Czechowicz M., Lewandowska-Polak A., Jarzebska M., Kowalski M.L. Mast cell and eosinophil activation during early phase of grass pollen-induced ocular allergic reaction. Allergy Asthma Proc. 2011, 32:43-48.
31. Johansson S.G., Bieber T., Dahl R., Friedmann P.S., Lanier B.Q., Lockey R.F., Motala C., Ortega Martell J.A., Platts-Mills T.A., Ring J., Thien F., Van Cauwenberge P., Williams H.C. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J.Allergy Clin. Immunol. 2004, 113:832-836.
32. Johansson S.G., Hourihane J.O., Bousquet J., Bruijnzeel-Koomen C., Dreborg S., Haahtela T., Kowalski M.L., Mygind N., Ring J., van Cauwenberge P., van Hage-Hamsten M., Wuthrich B. Arevised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001, 56:813-824.
33. Kitaichi N., Shimizu T., Honda A., Abe R., Ohgami K., Shiratori K., Shimizu H., Ohno S. Increase in macrophage migration inhibitory factor levels in lacrimal fluid of patients with severe atopic dermatitis. Graefes Arch. Clin. Exp. Ophthalmol. 2006, 244:825-828.
34. Lambiase A., Bonini S., Micera A., Magrini L., Bracci-Laudiero L., Aloe L. Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells. Invest. Ophthalmol. Vis. Sci. 1995, 36:2127-2132.
35. Leonardi A. Role of histamine in allergic conjunctivitis. Acta Ophthalmol. Scand. Suppl. 2000, 18-21.
36. Leonardi A., Abelson M.B. Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans. Clin. Ther. 2003, 25:2539-2552.
37. Leonardi A., Battista M.C., Gismondi M., Fregona I.A., Secchi A.G. Antigen sensitivity evaluated by tear-specific and serum-specific IgE, skin tests, and conjunctival and nasal provocation tests in patients with ocular allergic disease. Eye (Lond) 1993, 7(Pt 3):461-464.
38. Leonardi A., Bogacka E., Fauquert J.L., Kowalski M.L., Groblewska A., Jedrzejczak-Czechowicz M., Doan S., Marmouz F., Demoly P., Delgado L. Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. Allergy 2012, 67:1327-1337.
39. Leonardi A., Borghesan F., Avarello A., Plebani M., Secchi A.G. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis. Br. J. Ophthalmol. 1997, 81:23-26.
40. Leonardi A., Borghesan F., DePaoli M., Plebani M., Secchi A.G. Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis. Exp. Eye Res. 1998, 67:105-112.
41. Leonardi A., Borghesan F., Faggian D., Depaoli M., Secchi A.G., Plebani M. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases. Am. J. Ophthalmol. 2000, 129:151-158.
42. Leonardi A., Borghesan F., Faggian D., Secchi A., Plebani M. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy 1995, 50:610-613.
43. Leonardi A., Bremond-Gignac D., Bortolotti M., Violato D., Pouliquen P., Delval L., Grouin J.M., Fregona I.A. Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients. Br. J. Ophthalmol. 2007, 91:1662-1666.
44. Leonardi A., Brun P., Abatangelo G., Plebani M., Secchi A.G. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis. Invest. Ophthalmol. Vis. Sci. 2003, 44:3052-3058.
45. Leonardi A., Brun P., Sartori M.T., Cortivo R., Dedominicis C., Saggiorato G., Abatangelo G., Secchi A.G. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis. Invest. Ophthalmol. Vis. Sci. 2005, 46:1364-1370.
46. Leonardi A., Brun P., Tavolato M., Plebani M., Abatangelo G., Secchi A.G. Tumor necrosis factor-alpha (TNF-alpha) in seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Eur. J. Ophthalmol. 2003, 13:606-610.
47. Leonardi A., Busato F., Fregona I., Plebani M., Secchi A.G. Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model. Br. J. Ophthalmol. 2000, 84:1228-1232.
48. Leonardi A., Curnow S.J., Zhan H., Calder V.L. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin. Exp. Allergy 2006, 36:777-784.
49. Leonardi A., De Dominicis C., Motterle L. Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities. Curr. Opin. Allergy Clin. Immunol. 2007, 7:429-435.
50. Leonardi A., DeFranchis G., Zancanaro F., Crivellari G., De Paoli M., Plebani M., Secchi A.G. Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry. Invest. Ophthalmol. Vis. Sci. 1999, 40:3036-3040.
51. Leonardi A., Di Stefano A., Motterle L., Zavan B., Abatangelo G., Brun P. Transforming growth factor-beta/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis. Clin. Exp. Allergy 2011, 41:52-60.
52. Leonardi A., Di Stefano A., Vicari C., Motterle L., Brun P. Histamine H4 receptors in normal conjunctiva and in vernal keratoconjunctivitis. Allergy 2011, 66:1360-1366.
53. Leonardi A., Fregona I.A., Plebani M., Secchi A.G., Calder V.L. Th1- and Th2-type cytokines in chronic ocular allergy. Graefes Arch. Clin. Exp. Ophthalmol. 2006, 244:1240-1245.
54. Leonardi A., Jose P.J., Zhan H., Calder V.L. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. Ophthalmology 2003, 110:487-492.
55. Leonardi A., Lazzarini D., Motterle L., Bortolotti M., Deligianni V., Curnow S.J., Bonini S., Fregona I.A. Vernal Keratoconjunctivitis-like disease in adults. Am. J. Ophthalmol. 2013, 155(5):796-803.
56. Leonardi A., Sathe S., Bortolotti M., Beaton A., Sack R. Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients. Allergy 2009, 64:710-717.
57. Magrini L., Bonini S., Centofanti M., Schiavone M., Bonini S. Tear tryptase levels and allergic conjunctivitis. Allergy 1996, 51:577-581.
58. Martinez R., Acera A., Soria J., Gonzalez N., Suarez T. Allergic mediators in tear from children with seasonal and perennial allergic conjunctivitis. Arch. Soc. Esp. Oftalmol. 2011, 86:187-192.
59. Miller S., Cook E., Graziano F., Spellman J., Yanni J. Human conjunctival mast cell responses invitro to various secretagogues. Ocul. Immunol. Inflamm. 1996, 4:39-50.
60. Mimura T., Usui T., Mori M., Funatsu H., Noma H., Amano S. Rapid immunochromatographic measurement of specific tear immunoglobulin E in moderate to severe cases of allergic conjunctivitis with Immfast Check J1 in the spring. Cornea 2011, 30:524-527.
61. Mimura T., Usui T., Yamagami S., Miyai T., Amano S. Relation between total tear IgE and severity of acute seasonal allergic conjunctivitis. Curr. Eye Res. 2012, 37:864-870.
62. Montan P.G., van Hage-Hamsten M. Eosinophil cationic protein in tears in allergic conjunctivitis. Br. J. Ophthalmol. 1996, 80:556-560.
63. Montan P.G., van Hage-Hamsten M., Zetterstrom O. Sustained eosinophil cationic protein release into tears after a single high-dose conjunctival allergen challenge. Clin. Exp. Allergy 1996, 26:1125-1130.
64. Monzon S., Arrondo E., Bartra J., Torres F., Basagana M., Del Mar San Miguel M., Alonso R., Cistero-Bahima A. Conjunctivitis and total IgE in lacrimal fluid: Lacrytest screening. J.Allergy (Cairo) 2009, 2009:518903.
65. Motterle L., Diebold Y., Enriquez de Salamanca A., Saez V., Garcia-Vazquez C., Stern M.E., Calonge M., Leonardi A. Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis. Arch. Ophthalmol. 2006, 124:462-468.
66. Muromoto K., Shoji J., Inada N., Sawa M., Kato H. Tear eosinophil cationic protein measurement in patients with seasonal allergic conjunctivitis. Nihon Ganka Gakkai Zasshi 2006, 110:13-18.
67. Nakatani S., Ebihara N., Murakami A. Stem cell factor in the tear fluid of vernal keratoconjunctivitis patients. Jpn. J. Ophthalmol. 2007, 51:474-476.
68. Nivenius E., Montan P.G., Chryssanthou E., Jung K., van Hage-Hamsten M., van der Ploeg I. No apparent association between periocular and ocular microcolonization and the degree of inflammation in patients with atopic keratoconjunctivitis. Clin. Exp. Allergy 2004, 34:725-730.
69. Nivenius E., Van der Ploeg I., Gafvelin G., Van Hage M., Montan P.G. Conjunctival provocation with airborne allergen in patients with atopic keratoconjunctivitis. Clin. Exp. Allergy 2012, 42:58-65.
70. Nomura K., Takamura E. Tear IgE concentrations in allergic conjunctivitis. Eye (Lond) 1998, 12(Pt 2):296-298.
71. Oh J.W., Shin J.C., Jang S.J., Lee H.B. Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitis. Ann. Allergy Asthma Immunol. 1999, 82:579-585.
72. Pelikan Z. Cytological changes in tears during the secondary conjunctival response induced by nasal allergy. Br. J. Ophthalmol. 2012, 96:941-948.
73. Pong J.C., Chu C.Y., Chu K.O., Poon T.C., Ngai S.M., Pang C.P., Wang C.C. Identification of hemopexin in tear film. Anal. Biochem. 2010, 404:82-85.
74. Pong J.C., Chu C.Y., Li W.Y., Tang L.Y., Li L., Lui W.T., Poon T.C., Rao S.K., Lam D.S., Wang C.C., Pang C.P. Association of hemopexin in tear film and conjunctival macrophages with vernal keratoconjunctivitis. Arch. Ophthalmol. 2011, 129:453-461.
75. Proud D., Sweet J., Stein P., Settipane R.A., Kagey-Sobotka A., Friedlaender M.H., Lichtenstein L.M. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J.Allergy Clin. Immunol. 1990, 85:896-905.
76. Sacchetti M., Micera A., Lambiase A., Speranza S., Mantelli F., Petrachi G., Bonini S., Bonini S. Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis. Mol. Vis. 2011, 17:47-52.
77. Sack R., Conradi L., Beaton A., Sathe S., McNamara N., Leonardi A. Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments. Exp. Eye Res. 2007, 85:528-538.
78. Sack R.A., Conradi L., Krumholz D., Beaton A., Sathe S., Morris C. Membrane array characterization of 80 chemokines, cytokines, and growth factors in open- and closed-eye tears: angiogenin and other defense system constituents. Invest. Ophthalmol. Vis. Sci. 2005, 46:1228-1238.
79. Schlereth S., Lee H.S., Khandelwal P., Saban D.R. Blocking CCR7 at the ocular surface impairs the pathogenic contribution of dendritic cells in allergic conjunctivitis. Am. J. Pathol. 2012, 180:2351-2360.
80. Shoji J., Inada N., Sawa M. Antibody array-generated cytokine profiles of tears of patients with vernal keratoconjunctivitis or giant papillary conjunctivitis. Jpn. J. Ophthalmol. 2006, 50:195-204.
81. Shoji J., Inada N., Sawa M. Evaluation of eotaxin-1, -2, and -3 protein production and messenger RNA expression in patients with vernal keratoconjunctivitis. Jpn. J. Ophthalmol. 2009, 53:92-99.
82. Sirbikaite L., Ehlers N. The use of Lacrytest in ocular allergy. Acta Ophthalmol. Scand. 2007, 85:117.
83. Tabbara K.F. Tear tryptase in vernal keratoconjunctivitis. Arch. Ophthalmol. 2001, 119:338-342.
84. Uchio E., Matsuura N., Kadonosono K., Ohno S., Uede T. Tear osteopontin levels in patients with allergic conjunctival diseases. Graefes Arch. Clin. Exp. Ophthalmol. 2002, 240:924-928.
85. Uchio E., Ono S.Y., Ikezawa Z., Ohno S. Tear levels of interferon-gamma, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin. Exp. Allergy 2000, 30:103-109.
86. Venza I., Visalli M., Ceci G., Teti D. Quantitative determination of histamine in tears during conjunctivitis by a novel HPLC method. Ophthalmic Res. 2004, 36:62-69.
87. Wakamatsu T.H., Dogru M., Ayako I., Takano Y., Matsumoto Y., Ibrahim O.M., Okada N., Satake Y., Fukagawa K., Shimazaki J., Tsubota K., Fujishima H. Evaluation of lipid oxidative stress status and inflammation in atopic ocular surface disease. Mol. Vis. 2010, 16:2465-2475.
88. Wakamatsu T.H., Satake Y., Igarashi A., Dogru M., Ibrahim O.M., Okada N., Fukagawa K., Shimazaki J., Fujishima H. IgE and eosinophil cationic protein (ECP) as markers of severity in the diagnosis of atopic keratoconjunctivitis. Br. J. Ophthalmol. 2012, 96:581-586.
89. Wakamatsu T.H., Tanaka M., Satake Y., Dogru M., Fukagawa K., Igarashi A., Fujishima H. Eosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitis. Mol. Vis. 2011, 17:932-938.